Audit of the management of suspected giant cell arteritis in a large teaching hospital

Internal Medicine Journal

Volumn 32, Issue 7, 2002, Pages 315-319

  Dalbeth, N ^a,b   Lynch, N ^a   McLean, L ^a   McQueen, F ^a   Zwi, J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Audit; Corticosteroids; Giant cell arteritis; Osteoporosis; Temporal artery biopsy

Indexed keywords

CORTICOSTEROID; ETIDRONIC ACID; PREDNISONE;

ADULT; AGED; ARTICLE; BIOPSY; CONTROLLED STUDY; FEMALE; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; OSTEOPOROSIS; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; TEACHING HOSPITAL; TEMPORAL ARTERY;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HOSPITALS, TEACHING; HUMANS; MALE; MEDICAL AUDIT; METHYLPREDNISOLONE; MIDDLE AGED; NEW ZEALAND; OSTEOPOROSIS; PREDNISONE; RETROSPECTIVE STUDIES; TEMPORAL ARTERIES; TEMPORAL ARTERITIS;

EID: 0036379487     PISSN: 14440903     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1445-5994.2002.00225.x     Document Type: Article

References (14)

1. Hazleman B. Polymyalgia rheumatica and giant cell arteritis. In: Klippel JH, Dieppe PA (eds). Rheumatology. London: Mosby, 1998; 7.21.1-8.
2. Hall S, Lie JT, Kurland LT et al. The therapeutic impact of temporal artery biopsy. Lancet 1983; 2: 1217-20.
3. Ashton-Key M, Gallagher PJ. Surgical pathology of cranial arteritis and polymyalgia rheumatica. Baillieres Clin Rheumatol 1991; 5: 387-404.
4. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976; 51: 504-10.
5. Kyle V. Treatment of polymyalgia rheumatica/giant cell arteritis. Baillieres Clin Rheumatol 1991; 5: 485-92.
6. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis 1989; 48: 662-6.
7. Anon. Temporal artery biopsy [editorial]. Lancet 1983; 1: 396.
8. Allison MC, Gallagher PJ. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis 1984; 43: 416-17.
9. Achbar AA, Lie JT, Hunder GG et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994; 120: 987-92.
10. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis 1989; 48: 658-61.
11. Swannell AJ. Polymyalgia rheumatica and temporal arteritis: diagnosis and management. Br Med J 1997; 314: 1329-32.
12. Reid IR, Heap SW. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med 1990; 150: 2545-8.
13. Adachi JD, Benson WG, Brown J et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997; 337: 382-7.
14. Saag KG, Emkey R, Schnitzer TJ et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 1998; 339: 292-9.